Patents by Inventor K. Iain Cumming

K. Iain Cumming has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Delivery of a bioactive material
    Patent number: 8753683
    Abstract: A solid pharmaceutical composition comprising a water-soluble bioactive material and an encapsulating material which is present in the composition in the form of continuous solid phase, and in which solid particles of the bioactive material are dispersed and encapsulated in the continuous solid phase of the encapsulating material, wherein each of the bioactive material and the encapsulating material is normally a solid at room temperature and the melting point of the encapsulating material is lower than the melting point of the bioactive material, the bioactive material being preferably a bisphosphonate, most preferably alendronate, and the encapsulating material includes an enhancer, preferably a mono- or di-glyceride, or an encapsulating surfactant, preferably a polyoxyethylene/polyoxypropylene block copolymer having surface active properties, and a process for preparing the composition in which solid particles of the bioactive material are mixed with and dispersed in the encapsulating material which is in
    Type: Grant
    Filed: January 22, 2010
    Date of Patent: June 17, 2014
    Assignee: Merrion Research III Limited
    Inventors: Maurice Joseph Anthony Clancy, K. Iain Cumming, Conor B. Mc Crystal
  • Delivery of a Bioactive Material
    Publication number: 20100119611
    Abstract: A solid pharmaceutical composition comprising a water-soluble bioactive material and an encapsulating material which is present in the composition in the form of continuous solid phase, and in which solid particles of the bioactive material are dispersed and encapsulated in the continuous solid phase of the encapsulating material, wherein each of the bioactive material and the encapsulating material is normally a solid at room temperature and the melting point of the encapsulating material is lower than the melting point of the bioactive material, the bioactive material being preferably a bisphosphonate, most preferably alendronate, and the encapsulating material includes an enhancer, preferably a mono- or di-glyceride, or an encapsulating surfactant, preferably a polyoxyethylene/polyoxypropylene block copolymer having surface active properties, and a process for preparing the composition in which solid particles of the bioactive material are mixed with and dispersed in the encapsulating material which is in
    Type: Application
    Filed: January 22, 2010
    Publication date: May 13, 2010
    Inventors: Maurice Joseph Anthony Clancy, K. Iain Cumming, Conor B. Mc Crystal
  • Delivery of a bioactive material
    Patent number: 7670626
    Abstract: A solid pharmaceutical composition comprising a water-soluble bioactive material and an encapsulating material which is present in the composition in the form of continuous solid phase, and in which solid particles of the bioactive material are dispersed and encapsulated in the continuous solid phase of the encapsulating material, wherein each of the bioactive material and the encapsulating material is normally a solid at room temperature and the melting point of the encapsulating material is lower than the melting point of the bioactive material, the bioactive material being preferably a bisphosphonate, most preferably alendronate, and the encapsulating material includes an enhancer, preferably a mono- or di-glyceride, or an encapsulating surfactant, preferably, a polyoxyethylene/polyoxypropylene block copolymer having surface active properties, and a process for preparing the composition in which solid particles of the bioactive material are mixed with and dispersed in the encapsulating material which is in
    Type: Grant
    Filed: July 2, 2002
    Date of Patent: March 2, 2010
    Assignee: Merrion Research III Limited
    Inventors: Maurice Joseph Anthony Clancy, K. Iain Cumming, Conor B. McCrystal
  • Methods of treatment using a gastric retained losartan dosage
    Patent number: 7413751
    Abstract: A method of treatment for hypertension and other disease states is described, which comprises the delivery of losartan in a gastric retained dosage form.
    Type: Grant
    Filed: October 25, 2002
    Date of Patent: August 19, 2008
    Assignee: Depomed, Inc.
    Inventors: John Devane, K. Iain Cumming, Sui Yuen Eddie Hou, Gloria M. Gusler
  • Delivery of a bioactive material
    Publication number: 20040176328
    Abstract: A solid phannaceutical composition comprising a water-soluble bioactive material and an encapsulating material which is present in the composition in the form of continuous solid phase, and in which solid particles of the bioactive material are dispersed and encapsulated in the continuous solid phase of the encapsulating material, wherein each of the bioactive material and the encapsulating material is normally a solid at room temperature and the melting point of the encapsulating material is lower than the melting point of the bioactive material, the bioactive material being preferably a bisphosphonate, most preferably alendronate, and the encapsulating material includes an enhancer, preferably a mono- or di-glyceride, or an encapsulating surfactant, preferably, a polyoxyethylene/polyoxypropylene block copolymer having surface active properties, and a process for preparing the composition in which solid particles of the bioactive material are mixed with and dispersed in the encapsulating material which is in
    Type: Application
    Filed: December 22, 2003
    Publication date: September 9, 2004
    Inventors: Maurice Joseph Anthony Clancy, K. Iain Cumming, Conor B. Mc Crystal
  • Methods of treatment using a gastric retained losartan dosage
    Publication number: 20030158244
    Abstract: A method of treatment for hypertension and other disease states is described, which comprises the delivery of losartan in a gastric retained dosage form.
    Type: Application
    Filed: October 25, 2002
    Publication date: August 21, 2003
    Inventors: John Devane, K. Iain Cumming, Sui Yuen Eddie Hou, Gloria M. Gusler